Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Amgen patents

Patents where

Current Assignee

Name

Amgen

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7582631 Substituted heterocyclic compounds and methods of use	Patent 7582631 was granted and assigned to Amgen on September, 2009 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7582631	September 1, 2009
‌ US Patent 9517264 Human FGF receptor and β-Klotho binding proteins	Patent 9517264 was granted and assigned to Amgen on December, 2016 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	9517264	December 13, 2016
‌ US Patent 11607451 Self-buffering antibody formulations	Patent 11607451 was granted and assigned to Amgen on March, 2023 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11607451	March 21, 2023
‌ US Patent 7833979 Toxin peptide therapeutic agents	Patent 7833979 was granted and assigned to Amgen on November, 2010 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7833979	November 16, 2010
‌ US Patent 10569014 Device and method for making aseptic connections	Patent 10569014 was granted and assigned to Amgen on February, 2020 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	10569014	February 25, 2020
‌ US Patent 9061097 Drug delivery device	Patent 9061097 was granted and assigned to Amgen on June, 2015 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	9061097	June 23, 2015
‌ US Patent 10492990 Drug cassette, autoinjector, and autoinjector system	Patent 10492990 was granted and assigned to Amgen on December, 2019 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	10492990	December 3, 2019
‌ US Patent 11020537 Drug cassette, autoinjector, and autoinjector system	Patent 11020537 was granted and assigned to Amgen on June, 2021 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11020537	June 1, 2021
‌ US Patent 7919498 Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors	Patent 7919498 was granted and assigned to Amgen on April, 2011 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7919498	April 5, 2011
‌ US Patent 11878149 Drug delivery device	Patent 11878149 was granted and assigned to Amgen on January, 2024 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11878149	January 23, 2024
‌ US Patent 7442778 Modified Fc molecules	Patent 7442778 was granted and assigned to Amgen on October, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7442778	October 28, 2008
‌ US Patent 11351308 Auto-injector with signaling cap		Amgen	Amgen	United States Patent and Trademark Office	11351308	June 7, 2022
‌ US Patent 10092703 Drug cassette, autoinjector, and autoinjector system	Patent 10092703 was granted and assigned to Amgen on October, 2018 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	10092703	October 9, 2018
‌ US Patent 7429608 Benzo[	Patent 7429608 was granted and assigned to Amgen on September, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7429608	September 30, 2008
‌ US Patent 11266777 Drug delivery device, method of manufacture, and method of use	Patent 11266777 was granted and assigned to Amgen on March, 2022 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11266777	March 8, 2022
‌ US Patent 8227580 Human monoclonal antibodies to epidermal growth factor receptor	Patent 8227580 was granted and assigned to Amgen on July, 2012 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	8227580	July 24, 2012
‌ US Patent 7723490 Process for correction of a disulfide misfold in Fc molecules	Patent 7723490 was granted and assigned to Amgen on May, 2010 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7723490	May 25, 2010
‌ US Patent 7314933 Vanilloid receptor ligands and their use in treatments	Patent 7314933 was granted and assigned to Amgen on January, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7314933	January 1, 2008
‌ US Patent 7335672 Vanilloid receptor ligands and their use in treatments	Patent 7335672 was granted and assigned to Amgen on February, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7335672	February 26, 2008
‌ US Patent 11534547 Drug delivery systems and methods with pressure sensitive control	Patent 11534547 was granted and assigned to Amgen on December, 2022 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11534547	December 27, 2022
‌ US Patent 7439360 Vanilloid receptor ligands and their use in treatments	Patent 7439360 was granted and assigned to Amgen on October, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7439360	October 21, 2008
‌ US Patent 8008453 Modified Fc molecules	Patent 8008453 was granted and assigned to Amgen on August, 2011 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	8008453	August 30, 2011
‌ US Patent 11484648 Drug delivery device with container access system and related method of assembly	Patent 11484648 was granted and assigned to Amgen on November, 2022 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11484648	November 1, 2022
‌ US Patent 11305056 Needle insertion-retraction system having dual torsion spring system		Amgen	Amgen	United States Patent and Trademark Office	11305056	April 19, 2022
‌ US Patent 11583633 Systems and methods for delayed drug delivery	Patent 11583633 was granted and assigned to Amgen on February, 2023 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11583633	February 21, 2023

...

Results per page:

1,350 results

0 selected

1,350 results

0 selected